SC Filed 2021-04-23 Event — SEC 0001072613-21-000376 →

ARCH Venture Fund IX, L.P. → Karuna Therapeutics, Inc.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

9 13D/G filings on this issuer

8 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Karuna Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2023-06-21	SC	Sofinnova Venture Partners X, L.P.	—	—	view →
2022-09-20	SC	ARCH Venture Fund IX, L.P.	—	—	view →
2022-08-12	SC	PureTech Health LLC	—	—	view →
2021-11-12	SC	PureTech Health LLC	—	—	view →
2021-02-10	SC	PureTech Health plc	—	—	view →
2021-01-19	SC	ARCH Venture Fund IX, L.P.	—	—	view →
2020-08-26	SC	PureTech Health LLC	—	—	view →
2020-01-23	SC	PureTech Health LLC	—	—	view →

Other Filings by ARCH Venture Fund IX, L.P.

Filed	Form	Issuer	Stake	Shares
2022-09-20	SC	Karuna Therapeutics, Inc.	—	—	view →
2022-01-10	SC	Vir Biotechnology, Inc. VIR	—	—	view →
2021-07-12	SC	Vir Biotechnology, Inc. VIR	—	—	view →
2021-04-14	SC	Vir Biotechnology, Inc. VIR	—	—	view →
2021-01-19	SC	Karuna Therapeutics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →